Users Stopping Anti-Obesity Medications Regain Weight Far More Rapidly Compared to Dieters
New research reveals that people who stop using new weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end conventional diet and exercise programs.
Research printed in a leading health publication demonstrates that while obese individuals often shed substantial amounts of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"People buying these medications should be informed of the risk of fast weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to original mass in about a year and a half.
Comparing Therapies
The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
The team emphasize that people who shed pounds through diet and exercise generally have a more gradual creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Quick Regain
Doctors suggest the mode of action of the jabs accounts for the heightened weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating far more likely."
A Chronic Issue?
Health authorities suggest the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts contend that, given the likelihood of relapse, the treatment is often life-long.
This perspective is echoed by drug manufacturers, who say that the findings "highlight the persistent character of obesity," comparing it to managing diseases like hypertension.
User Accounts
People who have discontinued the jabs report a intense return of cravings.
"I experienced a switch activating and you're instantly starving," described one woman.
This difficulty is exacerbated if individuals have not developed permanent lifestyle or habit modifications during therapy.
Significant Use
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Adoption is higher among women compared to males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Finally, clinicians caution that while these medications are powerful agents for shedding pounds, they are not a magic cure and long-term success hinges on integrated lifestyle support.
